Effect of oral semaglutide compared with placebo and subcutaneous semaglutide on glycemic control in patients with type 2 diabetes: a randomized clinical trial
… The 26-week treatment period was followed by a 5-week follow-up period and visit at week 31. The trial protocol and statistical analysis plan are available in Supplement 1. …..... Read More